Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Asset Utilization Ratio (2021 - 2024)

Solid Biosciences' Asset Utilization Ratio history spans 4 years, with the latest figure at 0.0 for Q3 2024.

  • For Q3 2024, Asset Utilization Ratio rose 97.2% year-over-year to 0.0; the TTM value through Sep 2024 reached 0.0, up 97.2%, while the annual FY2022 figure was 0.03, 51.32% down from the prior year.
  • Asset Utilization Ratio for Q3 2024 was 0.0 at Solid Biosciences, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.06 in Q2 2022 and bottomed at 0.04 in Q3 2023.
  • The 4-year median for Asset Utilization Ratio is 0.01 (2021), against an average of 0.01.
  • The largest annual shift saw Asset Utilization Ratio surged 181.74% in 2022 before it plummeted 203.8% in 2023.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.04 in 2021, then decreased by 5.27% to 0.04 in 2022, then crashed by 103.22% to 0.0 in 2023, then rose by 9.8% to 0.0 in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Asset Utilization Ratio are 0.0 (Q3 2024), 0.0 (Q2 2024), and 0.0 (Q1 2024).